Genocea Biosciences Release: Novel T Cell Antigen Discovery Platform Providing New Momentum on Malaria Vaccine

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences today announced that it will highlight new progress it is making toward the development of an effective vaccine for malaria during a presentation today at the World Vaccine Congress by Jessica Baker Flechtner, Ph.D., Vice President of Research. Dr. Flechtner’s presentation will showcase the company’s novel approach to discovering vaccine candidates derived from antigens that stimulate the T cell arm of the immune system.

Back to news